Resolution of organ-specific complications of human immunodeficiency virus infection in children with use of highly active antiretroviral therapy

Clinical Infectious Diseases

Volumn 32, Issue 3, 2001, Pages 464-468

  Saulsbury, F T ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; DIDANOSINE; LAMIVUDINE; RITONAVIR; VIRUS RNA; ZIDOVUDINE;

ARTICLE; CARDIOMYOPATHY; CASE REPORT; CLINICAL FEATURE; ERYTHROCYTE APLASIA; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INFANT; KIDNEY DISEASE; LYMPHOCYTE COUNT; MALE; MORBIDITY; MORTALITY; PRIORITY JOURNAL; TREATMENT OUTCOME;

AIDS-ASSOCIATED NEPHROPATHY; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CARDIOMYOPATHIES; CD4 LYMPHOCYTE COUNT; CHILD; CHILD, PRESCHOOL; FEMALE; HIV; HIV INFECTIONS; HUMANS; INCIDENCE; INFANT; MALE; RED-CELL APLASIA, PURE; RNA, VIRAL;

EID: 0035116408     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/318493     Document Type: Article

References (33)

1. HIV-1 infection and the acquired immunodeficiency syndrome in children
2. Longlasting recovery in CD4 T-cell function and viral-load reduction after highly active antiretroviral therapy in advanced HIV-1 disease
3. Clinical and immuno-virologic characterization of the efficacy of stavudine, lamivudine, and indinavir in human immunodeficiency virus infection
4. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection
5. Eradication of AIDS-related disseminated Mycobacterium avium complex infection after 12 months of antimycobacterial therapy combined with highly active antiretroviral therapy
6. Treatment of AIDS-associated progressive multifocal leukoencephalopathy with highly active antiretroviral therapy
7. Loss of cytomegalovirus (CMV) viraemia following highly active antiretroviral therapy in the absence of specific anti-CMV therapy
8. Negative result of cytomegalovirus blood culture with restoration of CD4+ T-cell reactivity to cytomegalovirus after HAART in an HIV-1-infected patient
9. Withdrawal of Mycobacterium avium complex suppressive therapy in HIV-1-infected patients on highly active antiretroviral therapy
10. Discontinuation of Mycobacterium avium complex prophylaxis in patients with a rise in CD4 cell count following highly active antiretroviral therapy
11. Discontinuation of primary prophylaxis against Pneumocystis carinii pneumonia in HIV-1-infected adults treated with combination antiretroviral therapy
12. Can chemoprophylaxis against opportunistic infections be discontinued after an increase in CD4 cells induced by highly active antiretroviral therapy?
13. Discontinuation of Pneumocystis carinii pneumonia prophylaxis after start of highly active antiretroviral therapy in HIV-1 infection
14. Cardiac manifestations of acquired immune deficiency syndrome
15. Survival in children with perinatally acquired human immunodeficiency virus type 1 infection
16. Symptomatic cardiac dysfunction in children with human immunodeficiency virus infection
17. Left ventricular structure and function in children infected with human immunodeficiency virus
18. Cardiovascular and renal complications of HIV infection
19. Incidence of dilated cardiomyopathy and detection of HIV in myocardial cells of HIV-positive patients
20. The detection of viral genomes by polymerase chain reaction in the myocardium of pediatric patients with advanced HIV disease
21. Persistent B19 parvovirus infection in patients infected with human immunodeficiency virus type 1 (HIV-1): A treatable cause of anemia in AIDS
22. Red cell aplasia responsive to immunoglobulin therapy as initial manifestation of human immunodeficiency virus infection
23. Persistent parvovirus B19 related anemia of seven years' duration in an HIV-infected patient: Complete remission associated with highly active antiretroviral therapy
24. CD4-cell count in HIV-1-infected individuals remaining viraemic with highly active antiretroviral therapy (HAART)
25. Immunoreconstitution after ritonavir therapy in children with human immunodeficiency virus infection revolves multiple lymphocyte lineages
26. Comparison of two dose regimens of zidovudine, in an open, randomized, multicentre study for severe HIV-related thrombocytopenia
27. Efficacy of protease inhibitor-based anti-retroviral therapy in severe HlV-associated thrombocytopenia unresponsive to AZT
28. AIDS-related glomerulopathy: Occurrence in specific risk groups
29. Nephrotic syndrome associated with acquired immunodeficiency syndrome in children
30. Childhood AIDS nephropathy: A 10-year experience
31. Zidovudine is beneficial in human immunodeficiency virus associated nephropathy
32. HIV-1-associated nephropathy and response to highly-active antiretroviral therapy
33. Resolution of HIV-associated nephrotic syndrome with highly active antiretroviral therapy delivered by gastrostomy tube